Seth Klarman started to build up the position in AVEO Pharmaceuticals in Q4 2010 and continued to invest until Q4 2011. Since then they sold 508 Thousand shares. The investor completely sold their stake between Q4 2012 and Q4 2014.
Avg closing price
Price range
Sold -383 Thousand shares
Q4 2014
Avg closing price
$9.14
Price range
$6.50
-
$11.70
Sold 21.9% shares (-107 Thousand shares)
Q2 2013
Avg closing price
$42.75
Price range
$23.40
-
$82.70
Sold 3.6% shares (-18.2 Thousand shares)
Q4 2012
Avg closing price
$74.72
Price range
$59.70
-
$104.70
Increased shares by 1.7% (+8.47 Thousand shares)
Q4 2011
Avg closing price
$161.70
Price range
$145.30
-
$173.50
Increased shares by 12.8% (+56.7 Thousand shares)
Q3 2011
Avg closing price
$175.67
Price range
$151.20
-
$207.70
Increased shares by 25.8% (+90.8 Thousand shares)
Q2 2011
Avg closing price
$167.44
Price range
$130.60
-
$206.60
Increased shares by 76.3% (+153 Thousand shares)
Q1 2011